Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia

F. Ravandi, C. Arana Yi, J. E. Cortes, M. Levis, S. Faderl, G. Garcia-Manero, E. Jabbour, M. Konopleva, S. O'Brien, Z. Estrov, G. Borthakur, D. Thomas, S. Pierce, M. Brandt, Keith Pratz, R. Luthra, M. Andreeff, H. Kantarjian

Research output: Contribution to journalLetterpeer-review

51 Scopus citations
Original languageEnglish (US)
Pages (from-to)1543-1545
Number of pages3
Issue number7
StatePublished - Jul 2014

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this